Amgen Inc: (NASD: AMGN)
$104.53
0.29 (0.28%)
Volume 3,526,999
04:00 PM ET
Zacks Rank: 3-Hold 
BROKERAGE REPORTS
0 items in cart
AMGEN INC [AMGN]
Reports for Purchase
Showing records 1 - 20 ( 130 total )
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Biotechnology - Q113 EPS Preview; Anticipate Solid but Not Necessarily Stellar Q113 Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 50.00 |
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Not a Bubble, but That Doesn?t Rule Out a Correction Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 25.00 |
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Biotechnology - February Should Be Down; Even So, Several Data Anomalies Raise Questions Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 25.00 |
|
Price: 24.95
|
|
Company: AMGEN INC Industry: MED-BIOMED/GENE New Rheumatologist Survey Highlights Importance of Enbrel Price Increases Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 25.00 |
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Little in the Way of Incremental News from Business Review Day Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 10.00 |
|
Price: 24.95
|
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Mixed Q412 Results, Solid FY13 Guidance; Stock Seems Fully Valued Here Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 25.00 |
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Biotechnology - Script Data Indicates 2012 Went Out with a Bit of a Whimper Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 25.00 |
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Biotechnology: PCSK9 Race - If You?re Not First, You?re Last Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 25.00 |
|
Price: 24.95
|
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Operational Flexibility on Full Display with Solid Q312 Beat/Raise Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 25.00 |
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Biotechnology -August Script Data Generally Upbeat Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 25.00 |
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Story Seems to Have Largely Played-Out, Downgrade to Neutral Provider: Robert W. Baird & Co., Inc. Analyst: RAYMOND C
Price: 25.00 |
|
Company: AMGEN INC Industry: MED-BIOMED/GENE Takeaways from 2012 Baird Health Care Conference. Provider: Robert W. Baird & Co., Inc. Analyst: COLDWELL E
Price: 25.00 |
|
Price: 24.95
|
